866.512.5511
"I have been taking the Nutrusta Ubiquinol for about two years and the benefits are amazing. This is the real deal."- William, Ubiquinol Ultra Customer
(143)
Restore youthful cardiac energy at the cellular level with patented VESISorb® delivery system which turns poorly-absorbed CoQ10 into water soluble nano-droplets that bypass digestion and are swiftly absorbed by mitochrodria to prevent oxidative damage and increase ATP production in cells.
Nutrusta™ Ubiquinol Ultra Increases Absorption By 696%!
Why Nutrusta™ Ubiquinol Ultra:
✔Absorbable: Ubiquinol Ultra is 6X more absorbable as comparable Ubiquinol products.
✔Affordable: ONE Ubiquinol Ultra will replace SIX capsules of similar dosage.
✔Potent: Each serving supplies 100 mg of pure & active Kaneka® QH ubiquinol.
✔Convenient: Just take ONE small, easy-to-swallow Ubiquinol Ultra softgel every day
✔Advanced: 100% water-soluble VESIsorb® form maximizes bioavailability
✔Clean: Non-GMO, Gluten-Free, and Made in the USA in a NSF & GMP certified manufacturing facility. BPA-free bottles.
✔Absorbable: Ubiquinol Ultra is 6X more absorbable as comparable Ubiquinol products.
✔Affordable: ONE Ubiquinol Ultra will replace SIX capsules of similar dosage.
✔Potent: Each serving supplies 100 mg of pure & active Kaneka® QH ubiquinol.
✔Convenient: Just take ONE small, easy-to-swallow Ubiquinol Ultra softgel every day
✔Advanced: 100% water-soluble VESIsorb® form maximizes bioavailability
✔Clean: Non-GMO, Gluten-Free, and Made in the USA in a NSF & GMP certified manufacturing facility. BPA-free bottles.
- 1. Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J. 2001;94(11):1112-1117.
- 2. Folkers K, Vadhanavikit S, Mortensen SA. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci U S A. 1985;82(3):901-904.
- 3. Trupp RJ, Abraham WT. Congestive heart failure. In: Rakel RE, Bope ET,eds. Rakel: Conn's Current Therapy 2002. 54th ed. New York: W. B. Saunders Company; 2002:306-313.
- 4. Belardinelli R, Mucaj A, Lacalaprice F, et al. Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J. 2006; 27(22):2675-2681
- 5. Belardinelli R, Mucaj A, Lacalaprice F, et al. Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure. Biofactors. 2005;25(1-4):137-145.
- 6. Tran MT, Mitchell TM, Kennedy DT, Giles JT. Role of coenzyme Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy. 2001;21(7):797-806.
- 7. Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J. 2001;94(11):1112-1117.
- >8. Rosenfeldt FL, Haas SJ, Krum H, et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007;21:297-306.
- 9. Lonnrot K, Tolvanen JP, Porsti I, Ahola T, Hervonen A, Alho H. Coenzyme Q10 supplementation and recovery from ischemia in senescent rat myocardium. Life Sci. 1999;64(5):315-323.
- 10. Rosenfeldt FL, Pepe S, Linnane A, et al. The effects of ageing on the response to cardiac surgery: protective strategies for the ageing myocardium. Biogerontology. 2002;3(1-2):37-40.
- 11. Langsjoen PH, Langsjoen AM. Overview of the use of CoQ10 in cardiovascular disease. Biofactors. 1999;9(2-4):273-284.
- 12. Hamilton SJ, Chew GT, Watts GF. Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care. 2009;32:810-812.
- 13. Kuettner A, Pieper A, Koch J, Enzmann F, Schroeder S. Influence of coenzyme Q(10) and cerivastatin on the flow-mediated vasodilation of the brachial artery: results of the ENDOTACT study. Int J Cardiol. 2005;98(3):413-419.
- 14. Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J. 2007;28:2249-2255.
- 15. Dai YL, Luk TH, Yiu KH, et al. Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Atherosclerosis. 2011;216:395-401.
- 16. Gao L, Mao Q, Cao J, Wang Y, Zhou X, Fan L. Effects of coenzyme Q10 on vascular endothelial function in humans: A meta-analysis of randomized controlled trials. Atherosclerosis. 2011;221(2):311-316.
- 17. Rozen TD, et al Open label trial of coenzyme Q10 as a migraine preventive . Cephalalgia. (2002)
- 18. Sándor PS, et al Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial . Neurology. (2005)
- 19. Slater SK, et al A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine . Cephalalgia. (2011).
- 20. Bhagavan HN, Chopra RK: Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free radical research 2006, 40:445-453.
- 21. Liu ZX, Artmann C: Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system. Alternative therapies in health and medicine 2009, 15:42-46.
